Connect to other sites within the UBM Medica Network
A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.
Intraperitoneal Chemotherapy Improves Ovarian Cancer Survival
The use of intraperitoneal chemotherapy for the treatment of advanced ovarian cancer resulted in a survival benefit over intravenous chemotherapy.
Early-Onset Alopecia May Signal Chemotherapy Response for Ovarian Cancer
Onset of alopecia within the first 3 cycles of chemotherapy was associated with improved survival in ovarian cancer patients who completed 6 cycles of chemo.
Possible Target Found in ARID1A-Mutated Ovarian Cancers
Researchers have discovered that ovarian cancers with ARID1A mutations may be sensitive to treatment with an inhibitor of EZH2 methyltransferase activity.
Final Results of 9-Valent HPV Vaccine Show Extended Cancer Protection
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Factors Used for Prognosis in Advanced Cervical Cancer
A new study yielded nomograms for the assessment of locally advanced cervical cancer, with prognostic factors including histology, performance status, and others.
Phone Counseling Improves QOL in Cervical Cancer Survivors
Cervical cancer survivors saw improvements in self-reported quality-of-life outcomes with a psychosocial telephone counseling intervention, according to a new study.
Large Meta-Analysis Links Hormone Therapy With Ovarian Cancer Risk
A large meta-analysis found that women who were users of hormone therapy, even those with less than 5 years of use, had an increased risk of ovarian cancer.
ASCO: A Paradigm Shift in the Treatment of Endometrial Cancer
Don Dizon, MD, Brown University, discusses the paradigm shift in the treatment of endometrial cancer with the use of medical therapy, including chemotherapy with biologics, mTOR inhibitors combined with chemotherapy, and targeted therapies.
By clicking Accept, you agree to become a member of the UBM Medica Community.